Reporting Hub http://gpah.bsr.org/en/principles http://gpah.bsr.org/en/principles https://accesstomedicinefoundation.org/access-to-medicine-index/2021-ranking https://accesstomedicinefoundation.org/access-to-medicine-index/2021-ranking https://accesstomedicinefoundation.org/access-to-medicine-index/report-cards/johnson-johnson https://accesstomedicinefoundation.org/access-to-medicine-index/report-cards/johnson-johnson https://accesstomedicinefoundation.org/access-to-medicine-index/report-cards/johnson-johnson#pipeline-and-portfolio https://extranet.who.int/pqweb/medicines/prequalified-lists/finished-pharmaceutical-products Pricing transparency in the United States: In early 2021, we published our fifth annual Janssen U.S. Transparency Report, which highlights information related to our R&D investment, approach to pricing and patient support programs.